Sign in

    Marco Criscuolo

    Research Analyst at Nephron Research

    Marco Criscuolo is an Equity Research Associate at Nephron Research LLC, where he specializes in healthcare sector analysis, with a focus on medical devices and supplies. He began his finance career in 2018 after earning his undergraduate degree from Georgetown University's McDonough School of Business, and has previously held roles at Capital Performance Group, GIC, Innovo Solutions, Smith Charles Group, and Atlas Corps. At Nephron Research since late 2018, Criscuolo conducts deep primary research and supports actionable investment recommendations for clients, but available public sources do not attribute specific company coverage or provide third-party performance metrics for his research calls. His professional credentials do not presently indicate FINRA registration or securities licenses.

    Marco Criscuolo's questions to UNIVERSAL HEALTH SERVICES (UHS) leadership

    Marco Criscuolo's questions to UNIVERSAL HEALTH SERVICES (UHS) leadership • Q3 2024

    Question

    Marco Criscuolo of Nephron Research inquired about changes in managed care behavior, including patient denials and downgrades, and trends in physician recruitment and turnover.

    Answer

    Executive Steve Filton explained that aggressive payer behavior has been a trend for the past year, with no dramatic change in the current quarter. He noted that physician recruitment is not particularly difficult, and previous expense pressures in areas like anesthesiology were more related to billing changes from the No Surprise Act than physician scarcity.

    Ask Fintool Equity Research AI